The epigenetic silencing drug for chronic hepatitis B (HBV) is built on Tune’s TEMPO epigenetic editing platform, which is delivered to cells in lipid nanoparticles. Rather than irreversibly ...
Hepatitis C virus (HCV ... Finally, innovative vaccine candidates, such as nanoparticle-based vaccines displaying permuted E1E2 glycoproteins, have shown promise in eliciting robust neutralizing ...
DSPC:Chol:PEG–C–DMA:DLin–DMA (20:48:2:30)–siRNA Hepatitis B virus (yes ... and lower toxicity in comparison with inorganic nanoparticles and viral vectors. Function-engineerable ...
Axios Science on MSN2mon
Seattle firm targets hepatitis B through gene-editingA Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback